» Articles » PMID: 25431176

Genomewide Comprehensive Analysis Reveals Critical Cooperation Between Smad and C-Fos in RANKL-induced Osteoclastogenesis

Abstract

We have previously reported that transforming growth factor β (TGF-β) plays an essential role in receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis. However, the detailed underlying molecular mechanisms still remain unclear. Formaldehyde-assisted isolation of regulatory elements (FAIRE) and chromatin immunoprecipitation (ChIP) followed by sequencing (FAIRE-seq and ChIP-seq) analyses indicated the cooperation of Smad2/3 with c-Fos during osteoclastogenesis. Biochemical analysis and immunocytochemical analysis revealed that physical interaction between Smad2/3 and c-Fos is required for their nuclear translocation. The gene expression of nuclear factor of activated T-cells, cytoplasmic 1 (Nfatc1), a key regulator of osteoclastogenesis, was regulated by RANKL and TGF-β, and c-Fos binding to open chromatin sites was suppressed by inhibition of TGF-β signaling by SB431542. Conversely, Smad2/3 binding to Nfatc1 was impaired by c-Fos deficiency. These results suggest that TGF-β regulates RANKL-induced osteoclastogenesis through reciprocal cooperation between Smad2/3 and c-Fos.

Citing Articles

Unveiling the signal valve specifically tuning the TGF-β1 suppression of osteogenesis: mediation through a SMAD1-SMAD2 complex.

Wang Y, Luo C Cell Commun Signal. 2025; 23(1):38.

PMID: 39844165 PMC: 11752969. DOI: 10.1186/s12964-025-02051-z.


The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease.

Wu M, Wu S, Chen W, Li Y Cell Res. 2024; 34(2):101-123.

PMID: 38267638 PMC: 10837209. DOI: 10.1038/s41422-023-00918-9.


Interspecies Single-Cell RNA-Seq Analysis Reveals the Novel Trajectory of Osteoclast Differentiation and Therapeutic Targets.

Omata Y, Okada H, Uebe S, Izawa N, Ekici A, Sarter K JBMR Plus. 2022; 6(7):e10631.

PMID: 35866155 PMC: 9289986. DOI: 10.1002/jbm4.10631.


TGFβ1 Regulates Human RANKL-Induced Osteoclastogenesis via Suppression of NFATc1 Expression.

Tokunaga T, Mokuda S, Kohno H, Yukawa K, Kuranobu T, Oi K Int J Mol Sci. 2020; 21(3).

PMID: 31991837 PMC: 7038124. DOI: 10.3390/ijms21030800.


Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.

Omi M, Kaartinen V, Mishina Y J Biol Chem. 2019; 294(47):17818-17836.

PMID: 31619522 PMC: 6879329. DOI: 10.1074/jbc.RA119.009521.